AIM: To observe the clinical curative effect of calcium dobesilate capsule and yimaikang tablet for treating retinal vein occlusion(RVO).

METHODS:A total of 120 patients(167 eyes)with RVO were divided into 2 groups at random. The control group of 60 cases(82 eyes)were given calcium dobesilate capsule, and the treatment group of 60 cases(85 eyes)received calcium dobesilate capsule and yimaikang tablet. Changes of visual acuity and clinical effects after 3 courses of treatment were compared and analyzed for all patients.

RESULTS: Markedly effective 15 cases(23 eyes), effective 42 cases(57 eyes)and invalid 3 cases(5 eyes)in the 60 cases(85 eyes)of the treatment group, the total effective rate was 94.1%. Eighty-two eyes of 60 cases in the control group, markedly effective in 8 cases(12 eyes), effective 38 cases(49 eyes), ineffective 14 cases(21 eyes), The total effective rate was 74.4% in the control group. There were significant differences between the 2 groups of curative effect, and low incidence rate of adverse reaction.

CONCLUSION: Calcium dobesilate capsules and yimaikang tablet is effective and safe in the treatment of RVO.